Cubist Systematic Strategies’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-17,707
| Closed | -$195K | – | 2130 |
|
|
2017
Q2 | $195K | Buy |
+17,707
| New | +$195K | 0.01% | 1297 |
|
|
2017
Q1 | – | Sell |
-18,610
| Closed | -$201K | – | 2017 |
|
|
2016
Q4 | $201K | Sell |
18,610
-8,702
| -32% | -$94K | 0.02% | 1260 |
|
|
2016
Q3 | $280K | Buy |
27,312
+13,631
| +100% | +$140K | 0.02% | 1052 |
|
|
2016
Q2 | $179K | Buy |
+13,681
| New | +$179K | 0.01% | 1372 |
|
|
2015
Q3 | – | Sell |
-17,336
| Closed | -$170K | – | 2141 |
|
|
2015
Q2 | $170K | Buy |
+17,336
| New | +$170K | 0.01% | 1496 |
|
|
2015
Q1 | – | Sell |
-21,113
| Closed | -$185K | – | 2204 |
|
|
2014
Q4 | $185K | Sell |
21,113
-14,575
| -41% | -$128K | 0.01% | 1542 |
|
|
2014
Q3 | $246K | Buy |
35,688
+3,071
| +9% | +$21.2K | 0.02% | 1234 |
|
|
2014
Q2 | $172K | Buy |
+32,617
| New | +$172K | 0.01% | 1216 |
|